Jardiance Declared Best International Pharmaceutical Product 2018 Boehringer Ingelheim’s sodium-glucose co-transporter 2 (SGLT-2) inhibitor, Jardiance (empagliflozin), has been announced winner of the 2018 Prix Galien International Award in the category “Best...
Maternal mortality - Fact SheetMSD for Mothers Global statistics1 • Every day, approximately 830 women die from preventable causes related to pregnancy and childbirth. • 99% of all maternal deaths occur in developing countries. • Maternal mortality is...
Ahead of World Aids Day and as part of its continued commitment to ensuring access to quality, affordable antiretrovirals (ARV), Cipla is launching its new triple-combination ARV treatment for HIV in South Africa.
The HSV-1 herpes virus affects 67% of people globally under the age of 50.
The ultimate choice for women who want comfort and flexibility when expressing milk, is the Lansinoh® 2-in-1 Double Electric Breast Pump which features 3 pumping styles and 8 customisable suction levels.
Empagliflozin proven to improve clinical outcomes in real world practice across a broad spectrum of cardiovascular risk
The most recent 2018 treatment recommendations from the American Diabetes Association are that, after considering drug specific and patient factors, treatment for people with atherosclerotic cardiovascular disease (ASCVD) should begin with lifestyle management and metformin and subsequently incorporate an agent proven to reduce major adverse cardiovascular events and/or cardiovascular mortality.
Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of Emdolten®, a Dolutegravir-based triple combination anti-retroviral (ARV) treatment option.
Partnership brings established international brand to South African consumers with complementary barrier and cleansing presentations for dry skins.
Improving access to breast care nurses for all women is a priority in the South African breast health arena. Nurses are urged to sign up to a new, progressive online education portal which aims to make that possible, both in the public and private healthcare sectors.
It is estimated that three-and-a-half million South Africans (about 6% of the population), reported in 2012, suffer from diabetes and there are many more who remain undiagnosed.
Knife’s investment in PharmaScout will accelerate product rollout to pharmacies, medical practitioners and pharmaceutical warehouses and enhance new product development for the international market.
EXPERTS CALL FOR NATIONWIDE ADOPTION OF BUGWISE APP AMONG GPs TO KEEP ANTIBIOTIC RESISTANCE IN CHECK
Amid increased reporting of antibiotic resistance (ABR) worldwide, local health experts have called on South African doctors to more fully participate in and support efforts aimed at curbing the growing threat of antibiotic resistant superbugs in our country.
Muscle strain or spasm caused by injury, sport or work related accidents can be effectively relieved using South Africa’s most prescribed muscle relaxant brand, Norflex®.
With modern day stress and fast pace living, it is difficult to maintain high levels of energy necessary to keep going all day long. NRF B-Complex fizzy is a delicious, cranberry flavoured effervescent tablet with antioxidants which helps to boost energy effectively. A tablet should be taken daily in half a glass of water.
Novartis South Africa aims to continue building on local partnerships and health development initiatives, following the appointment of Dr. Mahomed (Mo) Kadwa as the company’s new Chief Executive Officer: Novartis South Africa and Head: Southern African Countries.